Amgen stock rises 3.05 percent as Amgen leadership explores AI-driven innovation in drug development

Traders Union
All News
Companies
Amgen rises 3.05% to $338.27 today

Highlights

AMGN is trading in a narrow range near $338, with price action capped by medium-term resistance and supported by long-term levels.
Momentum and trend indicators are mostly bearish or neutral, suggesting weak upward conviction and persistent selling pressure.
Expected trading range for the coming week is $329 to $345, with a downward bias and a low probability of a breakout.

Short-term bullish tilt as medium-term resistance contains advance

AMGN is trading at $338.27, above both the MA-20 ($332.62) and MA-200 ($328.62), but just below the MA-50 ($341.06), signaling a short-term upward bias with medium-term resistance and longer-term support still in place. The Ichimoku Kijun level on D1 stands at $335.03, which now acts as immediate support. Near-term support is clustered near MA-20 and the Ichimoku Kijun ($332.62–$335.03), with key support at the MA-200 ($328.62). Near-term resistance is defined by the MA-50 at $341.06, with key resistance at MA-100 ($350.24).

Seller persistence dominates despite intraday strength and range recovery

Momentum indicators paint a mixed picture on D1: MACD signals strong selling pressure while ADX is neutral, suggesting weak trend conviction. RSI and CCI on D1 are both in "Sell" territory, but with values around 41 and -83, they are not yet oversold; Stoch RSI is neutral at 28, while BBP registers as oversold, pointing to ongoing seller dominance. The Awesome Oscillator on D1 also supports a bearish stance. AMGN is trading at $338.27, up from last week's close of $336.88, reflecting a modest 0.41% gain. Price is now at the very top of its weekly range, with weekly volatility standing at 4.86%. This tone indicates a test of upper resistance and a recovery from the weekly low. In today's session, AMGN has surged 3.05%, showing notable intraday strength despite the generally overextended short-term oscillators.

Downside risk prevails with limited upside as weekly signals weaken

Looking ahead, the expected price corridor for the next week is $329–$345, in line with typical weekly volatility and recent price action. The probability of an upward move is very low (less than 20%), based on just one bullish signal from W1 moving averages and persistent bearish or neutral signals from the RSI-W1, ADX-W1, and MACD-W1. Downside risk is therefore more likely. Baseline scenario: AMGN trades sideways between $329 and $345, staying above major long-term supports but capped by medium-term resistance. A bullish breakout above $345 would require a decisive shift in momentum, with the next resistance at $350. Downside scenario sees the price falling below $329, opening the way for a move toward $323–$328 support. This expected range keeps AMGN well above its 52-week low of $267.83 and roughly mid-range relative to its 52-week high of $391.29.

Loading...

The tweet was deleted by the author.

But we saved everything 🙂.

Previously it was reported that Amgen shares were trading with mixed momentum despite regulatory and institutional tailwinds, suggesting a period of sideways consolidation. In light of recent developments, investors should monitor whether shifts in clinical pipeline news or trading volumes alter sentiment, with confirmation of a sustained trend requiring clear evidence of renewed price momentum.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.